Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-19

Clinical Trial Update: Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial [Phase 1, Phase 2]

View source ↗

Summary

This document indicates the completion of a Phase 1/Phase 2 clinical trial evaluating risperidone for civilian post-traumatic stress disorder conducted by Emory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperdal (risperidone)

Snippet

Sponsor: Emory University | Conditions: Post-Traumatic Stress Disorders | Phase 1, Phase 2 | Status: COMPLETED